# Applied Industrial Technologies Inc: financial statements, quarterly

AIT · NYSE · CIK 109563 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/ait.md) · [Financials](/companies/ait/financials.md) · [Filings](/companies/ait/filings.md) · [Insiders](/companies/ait/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ait/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | Q1 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,077](/filings/0000109563-25-000026.md) | [1,146](/filings/0000109563-25-000039.md) | [1,161 d](/filings/0000109563-26-000033.md) | [1,099](/filings/0000109563-25-000107.md) | [1,073](/filings/0000109563-26-000015.md) | [1,167](/filings/0000109563-26-000021.md) | [1,225 d](/filings/0000109563-26-000033.md) | [1,200](/filings/0000109563-26-000054.md) | [1,163](/filings/0000109563-26-000015.md) | [1,251](/filings/0000109563-26-000021.md) | [1,353 d](/filings/0000109563-26-000033.md) | [1,291](/filings/0000109563-26-000054.md) |
| Cost of revenue | $m | [760](/filings/0000109563-25-000026.md) | [808](/filings/0000109563-25-000039.md) | [804 d](/filings/0000109563-26-000033.md) | [774](/filings/0000109563-25-000107.md) | [745](/filings/0000109563-26-000015.md) | [811](/filings/0000109563-26-000021.md) | [850 d](/filings/0000109563-26-000033.md) | [838](/filings/0000109563-26-000054.md) | [810](/filings/0000109563-26-000015.md) | [871](/filings/0000109563-26-000021.md) | [941 d](/filings/0000109563-26-000033.md) | [899](/filings/0000109563-26-000054.md) |
| Gross profit | $m | [317](/filings/0000109563-25-000026.md) | [338](/filings/0000109563-25-000039.md) | [356 d](/filings/0000109563-26-000033.md) | [325](/filings/0000109563-25-000107.md) | [328](/filings/0000109563-26-000015.md) | [355](/filings/0000109563-26-000021.md) | [375 d](/filings/0000109563-26-000033.md) | [361](/filings/0000109563-26-000054.md) | [353](/filings/0000109563-26-000015.md) | [381](/filings/0000109563-26-000021.md) | [411 d](/filings/0000109563-26-000033.md) | [392](/filings/0000109563-26-000054.md) |
| Selling, general and administrative | $m | [202](/filings/0000109563-25-000026.md) | [217](/filings/0000109563-25-000039.md) | [217 d](/filings/0000109563-26-000033.md) | [212](/filings/0000109563-25-000107.md) | [207](/filings/0000109563-26-000015.md) | [226](/filings/0000109563-26-000021.md) | [240 d](/filings/0000109563-26-000033.md) | [232](/filings/0000109563-26-000054.md) | [230](/filings/0000109563-26-000015.md) | [243](/filings/0000109563-26-000021.md) | [252 d](/filings/0000109563-26-000033.md) | [249](/filings/0000109563-26-000054.md) |
| Operating income | $m | [115](/filings/0000109563-25-000026.md) | [121](/filings/0000109563-25-000039.md) | [139 d](/filings/0000109563-26-000033.md) | [113](/filings/0000109563-25-000107.md) | [121](/filings/0000109563-26-000015.md) | [129](/filings/0000109563-26-000021.md) | [135 d](/filings/0000109563-26-000033.md) | [129](/filings/0000109563-26-000054.md) | [123](/filings/0000109563-26-000015.md) | [138](/filings/0000109563-26-000021.md) | [159 d](/filings/0000109563-26-000033.md) | [144](/filings/0000109563-26-000054.md) |
| Income tax | $m | [24.4](/filings/0000109563-25-000026.md) | [25.4](/filings/0000109563-25-000039.md) | [37.4 d](/filings/0000109563-26-000033.md) | [24.0](/filings/0000109563-25-000107.md) | [29.3](/filings/0000109563-26-000015.md) | [27.5](/filings/0000109563-26-000021.md) | [27.2 d](/filings/0000109563-26-000033.md) | [27.8](/filings/0000109563-26-000054.md) | [27.4](/filings/0000109563-26-000015.md) | [35.4](/filings/0000109563-26-000021.md) | [39.2 d](/filings/0000109563-26-000033.md) | [30.5](/filings/0000109563-26-000054.md) |
| Net income | $m | [91.2](/filings/0000109563-25-000039.md) | [97.2](/filings/0000109563-25-000039.md) | [103 d](/filings/0000109563-26-000033.md) | [92.1](/filings/0000109563-25-000107.md) | [93.3](/filings/0000109563-26-000015.md) | [99.8](/filings/0000109563-26-000021.md) | [108 d](/filings/0000109563-26-000033.md) | [101](/filings/0000109563-26-000054.md) | [95.3](/filings/0000109563-26-000015.md) | [99.8](/filings/0000109563-26-000021.md) | [119 d](/filings/0000109563-26-000033.md) | [110](/filings/0000109563-26-000054.md) |
| Diluted EPS | $ per share | [2.32](/filings/0000109563-25-000026.md) | [2.48](/filings/0000109563-25-000039.md) | not reported | [2.36](/filings/0000109563-25-000107.md) | [2.39](/filings/0000109563-26-000015.md) | [2.57](/filings/0000109563-26-000021.md) | not reported | [2.63](/filings/0000109563-26-000054.md) | [2.51](/filings/0000109563-26-000015.md) | [2.65](/filings/0000109563-26-000021.md) | not reported | [2.97](/filings/0000109563-26-000054.md) |
| Basic EPS | $ per share | [2.35](/filings/0000109563-25-000026.md) | [2.51](/filings/0000109563-25-000039.md) | not reported | [2.40](/filings/0000109563-25-000107.md) | [2.43](/filings/0000109563-26-000015.md) | [2.60](/filings/0000109563-26-000021.md) | not reported | [2.67](/filings/0000109563-26-000054.md) | [2.54](/filings/0000109563-26-000015.md) | [2.68](/filings/0000109563-26-000021.md) | not reported | [3.01](/filings/0000109563-26-000054.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | FY2026 (2026-06-30) | Q1 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | [388](/filings/0000109563-25-000107.md) | [419](/filings/0000109563-25-000107.md) | not reported | not reported | not reported | not reported |
| Current assets | $m | [1,682](/filings/0000109563-24-000024.md) | [1,768](/filings/0000109563-24-000033.md) | [1,770](/filings/0000109563-25-000080.md) | [1,810](/filings/0000109563-24-000104.md) | [1,615](/filings/0000109563-25-000026.md) | [1,691](/filings/0000109563-25-000039.md) | [1,747](/filings/0000109563-26-000033.md) | [1,765](/filings/0000109563-25-000107.md) | [1,748](/filings/0000109563-26-000015.md) | [1,581](/filings/0000109563-26-000021.md) | [1,579](/filings/0000109563-26-000054.md) | [1,554](/filings/0000109563-26-000054.md) |
| Total assets | $m | [2,783](/filings/0000109563-25-000026.md) | [2,855](/filings/0000109563-25-000039.md) | [2,952](/filings/0000109563-26-000033.md) | [3,003](/filings/0000109563-25-000107.md) | [3,045](/filings/0000109563-26-000015.md) | [3,116](/filings/0000109563-26-000021.md) | [3,176](/filings/0000109563-26-000033.md) | [3,185](/filings/0000109563-26-000054.md) | [3,159](/filings/0000109563-26-000015.md) | [2,989](/filings/0000109563-26-000021.md) | [3,010](/filings/0000109563-26-000054.md) | [2,984](/filings/0000109563-26-000054.md) |
| Current liabilities | $m | [449](/filings/0000109563-24-000024.md) | [468](/filings/0000109563-24-000033.md) | [501](/filings/0000109563-25-000080.md) | [478](/filings/0000109563-24-000104.md) | [429](/filings/0000109563-25-000026.md) | [474](/filings/0000109563-25-000039.md) | [526](/filings/0000109563-26-000033.md) | [498](/filings/0000109563-25-000107.md) | [475](/filings/0000109563-26-000015.md) | [537](/filings/0000109563-26-000021.md) | [612](/filings/0000109563-26-000054.md) | [538](/filings/0000109563-26-000054.md) |
| Total liabilities | $m | [1,175](/filings/0000109563-24-000024.md) | [1,186](/filings/0000109563-24-000033.md) | [1,263](/filings/0000109563-25-000080.md) | [1,251](/filings/0000109563-24-000104.md) | [1,251](/filings/0000109563-25-000026.md) | [1,288](/filings/0000109563-25-000039.md) | [1,331](/filings/0000109563-26-000033.md) | [1,302](/filings/0000109563-25-000107.md) | [1,285](/filings/0000109563-26-000015.md) | [1,129](/filings/0000109563-26-000021.md) | [1,148](/filings/0000109563-26-000054.md) | [1,099](/filings/0000109563-26-000054.md) |
| Long-term debt | $m | [572](/filings/0000109563-24-000024.md) | [572](/filings/0000109563-24-000033.md) | [572](/filings/0000109563-25-000080.md) | [572](/filings/0000109563-24-000104.md) | [572](/filings/0000109563-25-000026.md) | [572](/filings/0000109563-25-000039.md) | [572](/filings/0000109563-26-000033.md) | [572](/filings/0000109563-25-000107.md) | [572](/filings/0000109563-26-000015.md) | [347](/filings/0000109563-26-000021.md) | [262](/filings/0000109563-26-000054.md) | [282](/filings/0000109563-26-000054.md) |
| Current portion of debt | $m | [25.2](/filings/0000109563-24-000024.md) | [25.1](/filings/0000109563-24-000033.md) | [25.1](/filings/0000109563-25-000080.md) | [25.0](/filings/0000109563-24-000104.md) | [0.0](/filings/0000109563-25-000026.md) | [0.0](/filings/0000109563-25-000039.md) | [0.0](/filings/0000109563-26-000021.md) | not reported | not reported | [18.0](/filings/0000109563-26-000021.md) | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [1,608](/filings/0000109563-24-000024.md) | [1,669](/filings/0000109563-24-000033.md) | [1,689](/filings/0000109563-25-000080.md) | [1,752](/filings/0000109563-24-000104.md) | [1,794](/filings/0000109563-25-000026.md) | [1,827](/filings/0000109563-25-000039.md) | [1,845](/filings/0000109563-26-000033.md) | [1,884](/filings/0000109563-25-000107.md) | [1,874](/filings/0000109563-26-000015.md) | [1,860](/filings/0000109563-26-000021.md) | [1,862](/filings/0000109563-26-000054.md) | [1,884](/filings/0000109563-26-000054.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q4 FY2024 (2024-06-30) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | Q1 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [102 d](/filings/0000109563-25-000026.md) | [84.2 d](/filings/0000109563-25-000039.md) | [119 d](/filings/0000109563-26-000033.md) | [128](/filings/0000109563-25-000107.md) | [95.1 d](/filings/0000109563-26-000015.md) | [122 d](/filings/0000109563-26-000021.md) | [147 d](/filings/0000109563-26-000033.md) | [119](/filings/0000109563-26-000054.md) | [99.7 d](/filings/0000109563-26-000015.md) | [100 d](/filings/0000109563-26-000021.md) | [165 d](/filings/0000109563-26-000033.md) | [86.4](/filings/0000109563-26-000054.md) |
| Capital expenditure | $m | [5.5](/filings/0000109563-25-000026.md) | [7.5](/filings/0000109563-25-000039.md) | [7.5 d](/filings/0000109563-26-000033.md) | [5.5](/filings/0000109563-25-000107.md) | [5.2](/filings/0000109563-26-000015.md) | [7.5](/filings/0000109563-26-000021.md) | [8.9 d](/filings/0000109563-26-000033.md) | [7.3](/filings/0000109563-26-000054.md) | [6.3](/filings/0000109563-26-000015.md) | [4.7](/filings/0000109563-26-000021.md) | [5.3 d](/filings/0000109563-26-000033.md) | [13.0](/filings/0000109563-26-000054.md) |
| Dividends paid | $m | [13.6 d](/filings/0000109563-25-000026.md) | [14.4 d](/filings/0000109563-25-000039.md) | [14.4 d](/filings/0000109563-26-000033.md) | [14.2](/filings/0000109563-25-000107.md) | [14.3 d](/filings/0000109563-26-000015.md) | [17.7 d](/filings/0000109563-26-000021.md) | [17.5 d](/filings/0000109563-26-000033.md) | [17.4](/filings/0000109563-26-000054.md) | [17.3 d](/filings/0000109563-26-000015.md) | [19.0 d](/filings/0000109563-26-000021.md) | [18.9 d](/filings/0000109563-26-000033.md) | [18.8](/filings/0000109563-26-000054.md) |
| Share repurchases | $m | [10.7 d](/filings/0000109563-25-000026.md) | [18.2 d](/filings/0000109563-25-000039.md) | [44.5 d](/filings/0000109563-26-000033.md) | [10.0](/filings/0000109563-25-000107.md) | [20.1 d](/filings/0000109563-26-000015.md) | [49.7 d](/filings/0000109563-26-000021.md) | [73.0 d](/filings/0000109563-26-000033.md) | [53.2](/filings/0000109563-26-000054.md) | [90.2 d](/filings/0000109563-26-000015.md) | [93.0 d](/filings/0000109563-26-000021.md) | [80.8 d](/filings/0000109563-26-000033.md) | [80.0](/filings/0000109563-26-000054.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-12-31) | Q3 FY2023 (2023-03-31) | Q1 FY2024 (2023-09-30) | Q2 FY2024 (2023-12-31) | Q3 FY2024 (2024-03-31) | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q1 FY2027 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [39.2](/filings/0000109563-24-000024.md) | [39.3](/filings/0000109563-24-000033.md) | [39.3](/filings/0000109563-24-000104.md) | [39.3](/filings/0000109563-25-000026.md) | [39.3](/filings/0000109563-25-000039.md) | [38.9](/filings/0000109563-25-000107.md) | [39.0](/filings/0000109563-26-000015.md) | [38.8](/filings/0000109563-26-000021.md) | [38.3](/filings/0000109563-26-000054.md) | [38.1](/filings/0000109563-26-000015.md) | [37.7](/filings/0000109563-26-000021.md) | [37.2](/filings/0000109563-26-000054.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 36,514,982 at 2026-10-16, from the cover of the [10-Q filed 2026-10-27](/filings/0000109563-26-000054.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 27, 2026, 21:29 ET. No prices; not investment advice.